Valuation : Baxter International Inc.

Market Cap 13.44B 11.59B 10.91B 9.94B 18.69B 1,276B 18.79B 129B 50.19B 649B 50.47B 49.37B 2,152B P/E 2026 *
33.3x
P/E 2027 * 21.7x
Enterprise Value 20.34B 17.54B 16.5B 15.03B 28.27B 1,930B 28.43B 195B 75.94B 982B 76.36B 74.71B 3,256B EV / Sales 2026 *
1.75x
EV / Sales 2027 * 1.67x
Free-Float
75.38%
Yield 2026 *
0.15%
Yield 2027 * 0.15%
1 day-0.46%
1 week-1.52%
Current month-0.42%
1 month-7.86%
3 months+40.71%
6 months+31.49%
Current year+35.48%
1 week 25.78
Extreme 25.785
26.76
1 month 25.75
Extreme 25.75
28.38
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 2025-07-31
Director of Finance/CFO 52 2026-03-15
Chief Tech/Sci/R&D Officer 57 2023-12-31
Director TitleAgeSince
Director/Board Member 66 2019-02-17
Director/Board Member 65 2018-12-31
Director/Board Member 69 2021-02-14
Date Insider Type Main position Quantity % Market Cap. Importance
6/2/26 Tax

President, Adv. Surgery

-153 0.0000% -
6/2/26 Tax

President, CCS

-321 0.0001% -
6/1/26 Free

Chief Financial Officer

13,426 0.0026%
Change 5-day change 1-year change 3-year change Capi.($)
-0.44%-1.52%+7.12%-36.23% 13.44B
-0.53%-5.64%-16.64%+6.54% 191B
+2.37%+1.45%-0.93%+12.58% 116B
+2.12%+0.23%+11.52%+87.94% 61.75B
-0.23%-1.12%-0.26%-32.61% 51.24B
+1.18%-0.02%+29.30%+54.07% 51.51B
-0.22%+1.66%+21.99%-11.05% 34.36B
+2.61%+1.04% - - 30.73B
-0.36%-2.38%+39.57%-16.56% 24.01B
+1.13%-1.96%-4.47%+15.32% 23.23B
Average +0.72%-1.46%+9.69%+8.89% 59.73B
Weighted average by Cap. +0.64%-1.93%+1.09%+14.73%

Financials

2026 *2027 *
Net sales 11.62B 10.02B 9.43B 8.59B 16.15B 1,103B 16.24B 111B 43.38B 561B 43.62B 42.67B 1,860B 11.86B 10.23B 9.63B 8.77B 16.49B 1,126B 16.58B 114B 44.29B 573B 44.54B 43.57B 1,899B
Net income 372M 321M 302M 275M 517M 35.31B 520M 3.57B 1.39B 17.96B 1.4B 1.37B 59.55B 687M 593M 558M 508M 956M 65.24B 961M 6.59B 2.57B 33.19B 2.58B 2.53B 110B
Net Debt 6.9B 5.95B 5.6B 5.1B 9.59B 655B 9.64B 66.16B 25.75B 333B 25.89B 25.33B 1,104B 6.32B 5.45B 5.13B 4.67B 8.78B 600B 8.83B 60.59B 23.58B 305B 23.72B 23.2B 1,011B
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
26-09-01 US$25.92 -0.33% 2,062,127
26-08-31 US$26.00 -0.50% 3,992,222
26-08-28 US$26.13 +0.77% 3,960,470
26-08-27 US$25.93 -2.15% 4,500,341
26-08-26 US$26.50 +0.80% 5,186,560
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
26.00USD
Average target price
28.73USD
Spread / Average Target
+10.49%

Quarterly revenue - Rate of surprise